Characterization of α2-adrenergic receptor subtype-specific antibodies

Hitoshi Kurose, Jeffrey L. Arriza, Robert J. Lefkowitz

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)


Subtypes of α2-adrenergic receptors have been defined pharmacologically in a variety of mammalian tissues. The α2A, α2B, α2C, and most recently α2D subtypes have been characterized by their affinities for selective receptor antagonists and agonists. The genes that may encode the α2A, α2B, and α2C subtypes have been identified in human and rat. In human these genes are termed α2-C10, α2-C2, and α2-C4, respectively, based on their chromosomal localization, whereas three genes, designated RG20α2, RNGα2, and RG10α2, are thought to be the corresponding rat homologues. These assignments were based on the pharmacology of the cloned receptor genes expressed in transfected cells and on the detection of homologous mRNAs by Northern blot analyses in cell lines or tissues with pharmacologically defined α2-adrenergic receptors. However, the subtype assignment of cloned genes has not been fully resolved by these means. To help clarify the subtype assignment, we have raised antibodies against sequences from the divergent third intracellular loop of the human and rat α2-adrenergic receptors. These antibodies were found to be subtype specific in immunoprecipitating either the cloned receptors expressed by DNA transfection or the pharmacologically defined receptors prepared from various tissues. Our immunological data corroborate the assignments of α2-C2/RNGα2 as encoding the α2B subtype in NG108-15 cells and rat neonatal lung and of α2-C4/RG10α2 as encoding the α2C subtype in opossum kidney cells. Furthermore, antibodies against α2-C10 and RG20α2 but not α2-C2/RNG«2 or α2-C4/ RG10α2 were both found to recognize α2-adrenergic receptors expressed in rat submaxillary glands and in bovine pineal gland, two tissues with α2D pharmacology. Because three genes were identified in the rat and human genome, these data suggest that the pharmacologically defined "α2D receptor" is genetically of the α2A subtype.

Original languageEnglish
Pages (from-to)444-450
Number of pages7
JournalMolecular Pharmacology
Issue number3
Publication statusPublished - Mar 1993
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology


Dive into the research topics of 'Characterization of α2-adrenergic receptor subtype-specific antibodies'. Together they form a unique fingerprint.

Cite this